Aurobindo gets FDA approval for amoxicillin and clavulanate potassium for oral suspension
Aurobindo has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for amoxicillin and clavulanate potassium for oral suspension USP, 125 mg/31.25 mg per 5 mL and 250 mg/62.5 mg per 5 mL.